Navigation Links
LifeNet Health Introduces New Sports Medicine Bio-Implants
Date:12/8/2008

VIRGINIA BEACH, Va., Dec. 8 /PRNewswire-USNewswire/ -- LifeNet Health, a leading allograft bio-implant company, has released the KinetiGraft Tendon and the Triple Bunch Tendon, both offering new options for ligament reconstruction.

LifeNet Health's new bio-medical implants offer sports medicine physicians another alternative in repairing patient injuries. KinetiGraft Tendon and Triple Bunch Tendon can be used in the reconstruction of either the anterior or posterior cruciate ligament, as well as augmenting tendon instability.

"The KinetiGraft Tendon or the Triple Bunch Tendon presents a solution to an individual who wants to remain physically active after a sports injury. Our implants provide the safety record of Allowash XG(R) technology and offer that extra level of confidence for the surgeon. We know these implants can make a difference in a patient's health and help restore their mobility," says Craig Wolf, LifeNet Health Product Manager of Sports Medicine.

LifeNet Health's CEO Rony Thomas states, "LifeNet Health is advancing the marketplace in sports medicine. We strive to be the innovation leader with safety as our top priority with every implant we provide. Patients can be assured that the new bio-implants offer some of the best options for restoring health."

Since 1995, LifeNet Health has distributed more than two million bio-implants with no incidence of disease transmission linked to tissue screened and processed using LifeNet Health's proprietary Allowash XG(R) technology. "Surgeons can depend on us. We offer high-quality, safe bio-implants to save lives and restore health," states Thomas.

LifeNet Health, founded in 1982, is a full service biomedical tissue banking system and a leading non-profit organ and tissue donation agency whose mission is saving lives and restoring health. Known for its outstanding safety record and its unyielding commitment to quality, LifeNet Health provides recovery and processing services for musculoskeletal and cardiovascular tissues, distributing more than 300,000 biomedical implants every year to restore health to patients around the world.

For additional information about LifeNet Health, visit www.lifenethealth.org.


'/>"/>
SOURCE LifeNet Health
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. LifeNet Health and IMS Announce Partnership
2. LifeNet Health and LOPA Announce a Partnership
3. LifeNet Health Saves 303 Lives and Restores Health to 265,967 Patients in 2007
4. LifeNet Health(R) Unveils New Biomedical Spine Implant
5. ETEX and LifeNet Health, Inc. Enter Agreement
6. LifeNet Health Chief Scientific Officer Wins Award
7. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
8. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
9. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
10. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
11. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... February 09, 2016 , ... Tunnell Consulting, Inc. announced that Frédéric Lefebvre ... will focus on acquiring new accounts and work closely with existing Tunnell clients throughout ... brings to our European clients more than 15 years of experience in the pharmaceutical ...
(Date:2/9/2016)... NJ (PRWEB) , ... February 09, 2016 , ... ... Dorman, former Vice President for Public Policy for the National Organization for Rare ... patient advocacy groups to ensure their voices are heard throughout the drug regulatory ...
(Date:2/9/2016)... and LONDON , February 9, 2016 /PRNewswire/ ... tech replace paper and protect IP   ... laboratory notebook (ELN) will be rolled out in ... and development (R&D) and protect valuable IP. Users will be ... a specific researcher or experiment as part of the application, ...
(Date:2/9/2016)... 9, 2016 DelveInsight,s, ... report provides in depth insights on the ... the Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitors. The ... various stages of development including Discovery, Pre-clinical, ... and Preregistration. Report covers the product clinical ...
Breaking Biology Technology:
(Date:2/3/2016)... 4, 2016 --> --> ... M (105.0), up 1,187% compared with fourth quarter of 2014. ... 517.6 M (loss: 30.0). Earnings per share increased to SEK ... 537.4 M (neg: 74.7). , --> ... to SEK 2,900.5 M (233.6), up 1,142% compared with 2014. ...
(Date:2/2/2016)... , Feb. 2, 2016 This BCC ... bioinformatic market by reviewing the recent advances in ... that drive the field forward. Includes forecast through ... Identify the challenges and opportunities that exist in ... software solution developers, as well as IT and ...
(Date:2/1/2016)... February 1, 2016 Rising sales ... drive global touchfree intuitive gesture control market ... Rising sales of consumer electronics coupled with new technological ... size through 2020   ... with new technological advancements to drive global touchfree intuitive ...
Breaking Biology News(10 mins):